Artificial microRNA Seed Engineering for Specific Gene Knockdown
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nucleic acid modalities for gene expression regulation, such as microRNAs, suffer from low specificity and high off-target effects, necessitating the development of improved modulatory polynucleotides with enhanced target gene modulation and reduced off-target activity.
Innovation Solution
The development of artificial microRNAs, pre-microRNAs, and pri-microRNAs encoded by recombinant adeno-associated viruses (AAV) or plasmids, designed using specific design parameters and molecular scaffolds to enhance target gene modulation while minimizing off-target effects, utilizing modular elements and sequence motifs to achieve precise recognition and low guide-to-passenger strand ratios.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional microRNAs are used for gene regulation, then gene expression can be modulated, but specificity is low and off-target effects are high
Solution Approach 1:
The patent applies local quality by designing artificial microRNAs with optimized seed regions (nucleotides 2-8) that have enhanced complementarity to target mRNAs. The seed region is specifically engineered to improve binding affinity and specificity to the intended target while minimizing off-target effects. This localized optimization of the microRNA sequence at the critical seed region resolves the contradiction between achieving strong target modulation and maintaining high specificity.
Solution Approach 2:
The patent employs parameter changes by systematically varying key parameters of the microRNA sequence including the seed region composition, loop structure, and overall length. By optimizing these parameters, the invention achieves microRNAs with enhanced target specificity and reduced off-target effects. The design parameters are carefully tuned to balance binding affinity for the target gene with selectivity against off-target genes.
2Manufacturing precision
If artificial microRNA constructs are designed with enhanced target recognition, then specificity improves, but design complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the artificial microRNA construct into distinct functional modules: the seed region (nucleotides 2-8) for target recognition, the loop region for structural stability, and the flanking regions for processing. Each module is independently optimized for its specific function. This modular design approach enables precise control over target recognition while simplifying the overall design process through systematic assembly of standardized components.
Solution Approach 2:
The patent employs universality by creating a standardized platform for artificial microRNA design that can be applied to target any gene of interest. The core structural elements and design principles are universal and can be adapted to different target sequences. This multi-functional framework allows the same design methodology to generate high-specificity microRNAs for various therapeutic and research applications, reducing design complexity through reuse of proven elements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The designed modulatory polynucleotides demonstrate high target gene knock-down efficiency with minimal off-target activity, achieving target knock-down of up to 100% and maintaining vector genome integrity, thereby improving the specificity and efficacy of gene regulation.
Implementation Method 1
The mature microRNAs primarily bind to the 3' untranslated region (3'-UTR) of target messenger RNAs (mRNAs) through partially or fully pairing with the complementary sequences of target mRNAs
Data Source
Figure 1
Figure 2
AI summary
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of modulatory polynucleotides.